Suppr超能文献

纳入真实世界证据进行网络荟萃分析的方法。

Methods for the inclusion of real-world evidence in network meta-analysis.

机构信息

Biostatistics Research Group, Department of Health Sciences, University of Leicester, University Road, Leicester, LE1 7RH, UK.

School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

出版信息

BMC Med Res Methodol. 2021 Oct 9;21(1):207. doi: 10.1186/s12874-021-01399-3.

Abstract

BACKGROUND

Network Meta-Analysis (NMA) is a key component of submissions to reimbursement agencies world-wide, especially when there is limited direct head-to-head evidence for multiple technologies from randomised controlled trials (RCTs). Many NMAs include only data from RCTs. However, real-world evidence (RWE) is also becoming widely recognised as a valuable source of clinical data. This study aims to investigate methods for the inclusion of RWE in NMA and its impact on the level of uncertainty around the effectiveness estimates, with particular interest in effectiveness of fingolimod.

METHODS

A range of methods for inclusion of RWE in evidence synthesis were investigated by applying them to an illustrative example in relapsing remitting multiple sclerosis (RRMS). A literature search to identify RCTs and RWE evaluating treatments in RRMS was conducted. To assess the impact of inclusion of RWE on the effectiveness estimates, Bayesian hierarchical and adapted power prior models were applied. The effect of the inclusion of RWE was investigated by varying the degree of down weighting of this part of evidence by the use of a power prior.

RESULTS

Whilst the inclusion of the RWE led to an increase in the level of uncertainty surrounding effect estimates in this example, this depended on the method of inclusion adopted for the RWE. 'Power prior' NMA model resulted in stable effect estimates for fingolimod yet increasing the width of the credible intervals with increasing weight given to RWE data. The hierarchical NMA models were effective in allowing for heterogeneity between study designs, however, this also increased the level of uncertainty.

CONCLUSION

The 'power prior' method for the inclusion of RWE in NMAs indicates that the degree to which RWE is taken into account can have a significant impact on the overall level of uncertainty. The hierarchical modelling approach further allowed for accommodating differences between study types. Consequently, further work investigating both empirical evidence for biases associated with individual RWE studies and methods of elicitation from experts on the extent of such biases is warranted.

摘要

背景

网络荟萃分析(NMA)是向全球报销机构提交的关键组成部分,特别是当随机对照试验(RCT)中对多种技术的直接头对头证据有限时。许多 NMA 仅包含来自 RCT 的数据。然而,真实世界证据(RWE)也越来越被认为是有价值的临床数据来源。本研究旨在探讨将 RWE 纳入 NMA 的方法及其对有效性估计不确定性水平的影响,特别关注芬戈莫德的有效性。

方法

通过将其应用于复发性缓解型多发性硬化症(RRMS)的示例,研究了纳入 RWE 的一系列证据综合方法。进行了文献检索,以确定评估 RRMS 治疗的 RCT 和 RWE。为了评估纳入 RWE 对有效性估计的影响,应用了贝叶斯层次和适应性幂先验模型。通过使用幂先验来降低这部分证据的权重,来研究纳入 RWE 的影响。

结果

尽管在该示例中,纳入 RWE 导致围绕效应估计的不确定性水平增加,但这取决于采用的纳入 RWE 的方法。“幂先验”NMA 模型导致对芬戈莫德的稳定效应估计,但随着 RWE 数据权重的增加,可信区间的宽度也会增加。层次 NMA 模型在允许研究设计之间的异质性方面是有效的,但这也增加了不确定性的水平。

结论

在 NMA 中纳入 RWE 的“幂先验”方法表明,考虑 RWE 的程度会对整体不确定性水平产生重大影响。层次建模方法进一步允许适应研究类型之间的差异。因此,有必要进一步研究与个别 RWE 研究相关的偏差的实证证据以及从专家那里得出这种偏差程度的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba89/8502389/eac8370081ea/12874_2021_1399_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验